InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
82.82
(
1.02%
)
Bitcoin
70,164.91
(
2.41%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Shengli

Send PM Follow Ignore
Followers 10
Posts 625
Boards Moderated 0
Alias Born 03/12/2010

Shengli

Re: None

Monday, 01/03/2011 6:27:09 AM

Monday, January 03, 2011 6:27:09 AM

Post# of 97237
Unpopular Stocks Can Become Valuable New Friends: John Dorfman

Cancer Drugs

The final spot on the outliers list goes to Ariad Pharmaceuticals Inc., a Cambridge, Massachusetts, company working on small-molecule drugs to treat aggressive cancers. In May, Merck & Co. signed a licensing agreement to sell one of its drugs. Ariad sells for six times earnings.

http://www.bloomberg.com/news/2011-01-03/unpopular-stocks-can-be-valuable-new-friends-commentary-by-john-dorfman.html?cmpid=yhoo
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up